We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Fusionex | LSE:FXI | London | Ordinary Share | JE00B8BL8C53 | ORD NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 63.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMFXI
RNS Number : 6071S
Fusionex International PLC
22 December 2016
For Immediate Release 22 December 2016
Fusionex International PLC
("Fusionex" or "the Company")
Establishment of Employee Benefit Trust
Fusionex, a multi-award winning international software solutions provider specialising in Big Data Analytics, Artificial Intelligence and the Internet of Things ("IoT"), announces that an employee benefit trust, the Fusionex Employee Benefit Trust ("EBT"), has been set up to incentivise employees of the Company and its subsidiaries through the award of a specified number of ordinary shares in the capital of the Company ("Awards").
The Awards shall not be granted to contractors or the directors of the Company, and shall be subject to vesting and performance conditions.
It is proposed that the EBT will subscribe for 7,095,000 new ordinary shares in the capital of the Company ("New Ordinary Shares").
Application will be made for the New Ordinary Shares to be admitted to trading on AIM, and it is anticipated that admission will become effective on or around 30 December 2016. Following admission, the Company's issued share capital will consist of 54,395,000 ordinary shares. There are no shares in the capital of the Company held as treasury shares.
The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
For further information please contact:
Fusionex Through Buchanan Ivan Teh, Chief Executive Officer Yuen Choong Lai, Chief Financial Officer Darren Hopkins, Director of Investor Relations & Corporate Development Panmure Gordon (Nominated Adviser and Joint Broker) Andrew Godber, Alina Vaskina (Investment Banking) Charles Leigh-Pemberton (Corporate 0207 886 Broking) 2500 Peel Hunt LLP (Joint Broker) 0207 418 Richard Kauffer, Euan Brown 8900 Buchanan Sophie McNulty, Stephanie Watson, 0207 466 Patrick Hanrahan 5000
Market abuse regulation
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBGBDDUXDBGLD
(END) Dow Jones Newswires
December 22, 2016 05:45 ET (10:45 GMT)
1 Year Fusionex Chart |
1 Month Fusionex Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions